Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-03-10
1988-08-09
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548182, 548183, 548184, 548185, 548186, 548187, 548188, 548189, 548127, 548128, 548129, 548130, 548132, 548135, 548136, 548138, 548144, 548161, 548165, 548169, 548170, 548171, 548213, 548217, 548221, 548222, 548225, 548226, 548228, 548229, 548230, 548231, 548232, 548243, 548244, 548255, 548263, 548264, 548265, 548251, 548301, 548305, 548329, 548337, 548358, 548363, 548365, 548367, 548375, 548376, 549 62, 549 63, 549 64, 549 65, 549 66, 549475, 549476, 549477, 549478, 549479, 544315, 544316, 544317, 544318,
Patent
active
047628480
ABSTRACT:
Heterocyclic sulfides of the general formula heterocycle-S-R, a process for their preparation and, in particular, their use for immunostimulation, immunorestoration and cytostatic treatment, and pharmaceutical agents, which contain a sulfide of this type, for these indications.
REFERENCES:
patent: 2776976 (1957-01-01), D'Amico
patent: 2886487 (1959-05-01), Kupferberg et al.
patent: 3558775 (1971-01-01), Fournier
patent: 3629473 (1971-12-01), Doebel et al.
patent: 3671643 (1972-06-01), Kalopissis
patent: 3907822 (1975-09-01), Narayanan et al.
patent: 3950542 (1976-04-01), Kalopissis et al.
patent: 3962237 (1976-02-01), Boyle et al.
patent: 3984426 (1976-10-01), Winkelmann et al.
patent: 4002624 (1977-01-01), Trepanier
patent: 4018923 (1977-04-01), Lacefield et al.
patent: 4022607 (1977-05-01), Jackson
patent: 4035492 (1977-07-01), Kalopissis et al.
patent: 4065584 (1977-12-01), Lafon
patent: 4097669 (1978-06-01), Reisdorff et al.
patent: 4107438 (1978-08-01), Lafor
patent: 4139635 (1979-02-01), Kalopissis
patent: 4157392 (1979-06-01), Gullo et al.
patent: 4197307 (1980-04-01), Gallay et al.
patent: 4202901 (1980-05-01), Finch et al.
patent: 4251527 (1981-02-01), Gullo et al.
patent: 4379159 (1983-04-01), Cherkofsky
patent: 4396625 (1983-08-01), Yamanori et al.
patent: 4447440 (1984-05-01), Busse et al.
Chem. Abstracts, vol. 78; 71986x (1973).
Chem. Abstracts, vol. 97; 182418a (1982).
J. Heterocyclic Chem., vol. 5, pp. 387-391 (1968).
Progress in Drug Research, vol. 16, pp. 93-119 (1972).
Schleupner et al., Infection & Immunity, vol. 21, No. 3 (1978), pp. 886-895.
Johnson et al., Cancer Immunol., Immuno. Ther. 3, 219-227 (1978).
Kino et al., The J. of Antibiotics, Jul. 1985, pp. 936-940.
Foye, W., Principles of Medicinal Chemistry, 2nd Ed (1981), pp. 101, 102, 850, 851.
Mayer et al., Infection, 8 (1980) No. 1, pp. 1`21.
Bicker et al., J. Infectious Diseases, vol. 139, No. 1 (1979).
Watanabe et al., J. of Antibiotics, vol. 38, No. 2, pp. 1781-1787.
Goodman et al., The Pharmacological Basis of Therapeutics, 6 ed. p. 28.
Hino et al., Journal of Antibiotics, 38, 1985, pp. 926-935.
Blumbach Jurgen
Dickneite Gerhard
Durckheimer Walter
Limbert Michael
Scheunemann Karl-Heinz
Hoechst Aktiengesellschaft
Lee Mary C.
Richter J.
LandOfFree
1,3-thiazoles and their use as immunomodulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-thiazoles and their use as immunomodulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-thiazoles and their use as immunomodulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918863